Every day in the US, approximately 34 patients are removed from the transplant waiting list either because they die or they become too sick to receive a transplant.

Our mission is to bring that number down to zero by developing innovative technology and services that will extend the safe preservation times for unused kidneys.

The 34 Lives Leadership Team represents a combined 100+ years of experience in the fields of transplantation, healthcare, policy and technology.

CEO Chris Jaynes developed the equipment and technology for ex-vivo or out-of-body lung assessment and is using his background and previous successes to also improve kidney transplantation.

CCO and Co-founder Kathleen St. Jean built a 30-year career at Merck & Co., Inc., with a number of leadership roles in Sales, Professional Learning & Development and Customer Strategy.

Contact us at info@34lives.com


Biotechnology

Health Care

Life Sciences

Medical Devices

34 Lives

Org chart

Teams

Offices

Similar companies